James Evans

3.6k citations

64 papers · 2.2k indexed · 1 hit paper · h-index 21

Impact in

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Carcinogens and Genotoxicity Assessment
Molecular Biology top 5%
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering

Papers in

Internal Medicine 5
- Venous Thromboembolism Diagnosis and Management 5
Cancer Research 14
- Cancer, Hypoxia, and Metabolism 8
- Carcinogens and Genotoxicity Assessment 5

Co-authors: J. Martin Brown Christopher K. Patil Marjorie A. Oettinger Cordula U. Kirchgessner Tim Carter Christina A. Cuomo Julia Brown Mary S. Kovacs
Journals: Cancer Research (7 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Radiation Research (4 papers)Frontiers in Neurology (4 papers)Genes Chromosomes and Cancer (2 papers)
Partner nations: United States Australia Canada

In The Last Decade

James Evans

64 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

DNA-Dependent Kinase (p350) as a Candidate Gene for the Murine SCID Defect 1995 · 535 citations

Peers

Countries citing papers authored by James Evans

Since Specialization

Citations

This map shows the geographic impact of James Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Evans more than expected).

Fields of papers citing papers by James Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Evans. The network helps show where James Evans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Evans Line = papers co-authored together James Evans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TACTICS VR Stroke Telehealth Virtual Reality Training for Health Care Professionals Involved in Stroke Management at Telestroke Spoke Hospitals: Module Design and Implementation Study JMIR Serious Games ·Steven Maltby, Carlos García-Esperón, S. Bégué, Kenneth Butcher, James Evans, William F. O’Brien, 广琳, Astera Walizada, Natalie Wilson, Murielle G. Kluge, Amy McCormick Diduch, Christine Paul, Neil J. Spratt, Christopher Levi, Frederick R. Walker	2023	3
2	Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor regression Cancer Research ·Wadie D. Mahauad‐Fernandez, Yu Chi Yang, Ian Lai, S Phillip, Irini McMaster, James Evans, 耿一伊藤, Xinyu Chen, Aaron R. Folsom, G. Leslie Burnett, Bianca J. Lee, Nuntana Dinglasan, Nataliya Tovbis Shifrin, 泰杉山, Elsa Quintana, Adrian L. Gill, Jacqueline A.M. Smith, Mallika Singh, Dean W. Felsher	2023	1
3	Diagnostic Utility of Computed Tomography Perfusion in the Telestroke Setting Stroke ·Kavita Pol Nalawade, 单位韩, James Evans, William F. O’Brien, Timothy Ang, Carlos García-Esperón, Christopher Blair, Leon Edwards, Sam G. Russell, Candice Delcourt, Neil J. Spratt, Mark Parsons, Kenneth Butcher	2022	4
4	Radiation of meningioma dural tail may not improve tumor control rates Frontiers in Surgery ·Nathalie Neveux, Siyuan Yu, 哲也東島, Christian Fernandez, Nikolaos Mouchtouris, E. A. Kaverina, Desy Erika, Fatih Gide, Mahdi Gholampoor, 林幸谦, Boris Métral, Giyarpuram N. Prashant, Wenyin Shi, James Evans	2022	10
5	Telestroke Assessment With Perfusion CT Improves the Diagnostic Accuracy of Stroke vs. Mimic Frontiers in Neurology ·Novi Erma Ekowati, Longting Lin, Neil J. Spratt, Andrew Bivard, Sam G. Russell, James Evans, William F. O’Brien, Christopher Levi, Timothy Ang, Іван Чубар, Elizabeth Pepper, Carlos García-Esperón, Mark Parsons	2021	4
6	The Need for Structured Strategies to Improve Stroke Care in a Rural Telestroke Network in Northern New South Wales, Australia: An Observational Study Frontiers in Neurology ·Changzhi Du, Carlos García-Esperón, Thomas Lillicrap, Ferdinand Miteff, Pablo García-Bermejo, Ebru Nilgün SERENGİL, Sam G. Russell, William F. O’Brien, James Evans, Іван Чубар, Andrew Bivard, Mark Parsons, Jennifer J. Majersik, Neil J. Spratt, Christopher Levi, (unknown)	2021	4
7	No Evidence of the “Weekend Effect” in the Northern New South Wales Telestroke Network Frontiers in Neurology ·Thomas Lillicrap, Rezai Moghaddam Marjan, Ferdinand Miteff, Pablo García-Bermejo, Ebru Nilgün SERENGİL, Manuel Rueß, Billy O’Brien, James Evans, Іван Чубар, Andrew Bivard, Mark Parsons, Christopher Levi, Carlos García-Esperón, Neil J. Spratt	2020	5
8	Accuracy and Reliability of Multiphase CTA Perfusion for Identifying Ischemic Core Clinical Neuroradiology ·Fifih Alfi Wafiroh, Yin RongXiu, Nils D. Forkert, Karl Reyes, James Evans, Amith Sitaram, 蔡镕聪, Mohamed Najm, Bijoy K. Menon, Andrew M. Demchuk, Mayank Goyal, Rani Gupta Sah, Christopher D. d’Esterre, Philip A. Barber	2018	15
9	RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations Scientific Reports ·Marcus Fischer, Vincent Yeung, Fiore Cattaruzza, X. Yan, Wan-Ching Yen, Christopher L. Murriel, James Evans, Gilbert O’Young, Alayne Brunner, Min Wang, Jennifer Cain, Belinda Cancilla, Ann M. Kapoun, Timothy Hoey	2017	37
10	Novel finding of carbamazepine induced gall bladder granulomatous vasculitis Internal Medicine Journal ·José M Ceriani Cernadas, H.-G. Park, James Evans, Carolyn Orr	2014	4
11	Study 9: Replication of Vermeulen et al., 2010 (Nature Cell Biology) OSF Preprints (OSF Preprints) ·Nicole Perfito, (unknown), James Evans, Alexandria Denis, 恵利子斎藤, Hong Xin, Anthony Essex, Elizabeth Iorns, Rachel Tsui, Javier Pineda	2013	1
12	Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302 Molecular Cancer Therapeutics ·Fanying Meng, James Evans, Betzi Pérez‐Ortega, Monica Banica, Lingyun Lan, Gustavo Lorente, Jianxin Duan, Xiaohong Cai, Alexandra M. Mowday, Christopher P. Guise, Andrej Maroz, Robert F. Anderson, Adam V. Patterson, Gregory C. Stachelek, Peter M. Glazer, Mark D. Matteucci, Charles P. Hart	2011	160
13	In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302 Cancer Research ·Charles P. Hart, Fanying Meng, Monica Banica, James Evans, Lingyun Lan, Gustavo Lorente, Anri Anri, Mark Matteucci	2008	1
14	An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin International Journal of Radiation OncologyBiologyPhysics ·Zelanna Goldberg, James Evans, Geoffrey W. Birrell, J. Martin Brown	2001	12
15	Metabolism of tirapazamine by multiple reductases in the nucleus11Abbreviations: TPZ, tirapazamine; P450 reductase, NADPH:cytochrome P450 reductase; PMSF, phenylmethylsulfonyl fluoride; DTT, dithiothreitol; DHR123, dihydrorhodamine 123; DAPI, 4′,6-diamidino-2-phenylindole, dihydrochloride; SN, supernatant from nuclei; LS, low salt; HS, high salt; and NM, nuclear matrix. Biochemical Pharmacology ·Z.Q. You, James Evans, Jeffrey M. Brown	2001	56
16	Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin British Journal of Cancer ·Mary S. Kovacs, 植竹健司, James Evans, Martin Koch, Bradly G. Wouters, Julia Brown	1999	59
17	Adaptation of human tumor cells to tirapazamine under aerobic conditions Biochemical Pharmacology ·James H. Elwell, Bronwyn G. Siim, James Evans, Jeffrey M. Brown	1997	54
18	Chromosomal radiosensitivity at intrachromosomal telomeric sites Genes Chromosomes and Cancer ·Luis Álvarez, James Evans, Oluwaseun Samuel Ezekiel, J. N. Lucas, J. Martin Brown, Amato J. Giaccia	1993	73
19	The prediction of human tumor radiosensitivity in situ: An approach using chromosome aberrations detected by fluorescence in situ hybridization International Journal of Radiation OncologyBiologyPhysics ·J. Martin Brown, James Evans, Mary S. Kovacs	1992	56
20	Use of fluorescent in situ hybridization to detect chromosomal rearrangements in somatic cell hybrids Genes Chromosomes and Cancer ·Amato J. Giaccia, James Evans, J. Martin Brown	1990	11

About James Evans

James Evans is a scholar working on Internal Medicine, Cancer Research, Rehabilitation, Molecular Biology and Epidemiology, having authored 64 papers that have together received 2.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), Acute Ischemic Stroke Management (12 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer therapeutics and mechanisms (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Carcinogens and Genotoxicity Assessment (5 papers), Epigenetics and DNA Methylation (5 papers) and Stroke Rehabilitation and Recovery (4 papers). The work is most often cited by research in Cancer Research (797 citations), Molecular Biology (1.4k citations), Oncology (493 citations), Biotechnology (132 citations) and Immunology (218 citations). James Evans has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include J. Martin Brown, J. Martin Brown, Christopher K. Patil, Marjorie A. Oettinger, Cordula U. Kirchgessner, Tim Carter, Christina A. Cuomo, Julia Brown, Mary S. Kovacs and John F. Ward. Their work appears in journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics, Radiation Research, Frontiers in Neurology and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact